SG Americas Securities, LLC
Broker-DealerPosition in DNLI — Denali Therapeutics Inc.
CIK 1313360
NEW YORK, NY
Position in DNLI
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,088,959
+$193,433 QoQ
Shares Held
42,339
-9.2% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#124
of 290 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. DNLI ranks #67 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in DNLI
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,088,959 | 42,339 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $895,526 | 46,642 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,469,763 | 149,592 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $554,678 | 38,201 | Shares | Sole | 2025-10-23 | |
| 2025-03-31 | $657,522 | 48,365 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $224,241 | 11,003 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $140,057 | 4,808 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $320,621 | 13,808 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $146,533 | 7,141 | Shares | Sole | 2024-05-06 | |
| 2023-09-30 | $738,554 | 35,800 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $279,577 | 9,474 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $859,184 | 37,291 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $126,424 | 4,546 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $394,397 | 12,851 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,157,069 | 39,316 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $288,886 | 8,980 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,462,969 | 32,802 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,558,652 | 30,895 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,354,658 | 17,270 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,551,863 | 27,178 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,145,847 | 25,619 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $2,979,157 | 83,147 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $492,812 | 20,381 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $390,227 | 22,286 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||